CD274 and cancer: A bacterial cellulose injectable suspension immobilized with 131I-labeled anti-PD-L1 antibody (αPD-L1) was prepared for cancer radioimmunotherapy to address the problems of low response rates and immune-related adverse events caused by immune checkpoint blockade.